1204PTHREE DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER

commonly used concurrently with radiotherapy in terms of efficacy and safety. Methods: Histologically or cytologically proven patients with NSCLC were included in this study. Clinical data including gender, age, performance status, histological subtype, chemotherapy regimen were recorded. During the concurrent chemoradiation phase, patients were administered the following: cisplatin-etoposide (PE) arm: cisplatin